ANRO
Alto Neuroscience, Inc.
31.00$
+3.3%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Alto Neuroscience, Inc. (ANRO) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/27/2026 | Current report (8-K) | Alto Neuroscience, Inc. (ANRO): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits | View report ↗ |
| 08/12/2026 | Current report (8-K) | Alto Neuroscience, Inc. (ANRO): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/27/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/20/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/14/2026 | Current report (8-K) | Alto Neuroscience, Inc. (ANRO): Entry into a Material Definitive Agreement; Financial Statements and Exhibits | View report ↗ |
| 07/14/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 07/13/2026 | Current report (8-K) | Alto Neuroscience, Inc. (ANRO): Results of Operations and Financial Condition; Other Events | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.